Methyl tridecanoate

CAS No. 1731-88-0

Methyl tridecanoate( methyl tridecanoate )

Catalog No. M29397 CAS No. 1731-88-0

Methyl tridecanoate inhibits β-amyloid aggregation moderately and inhibits acetylcholinesterase (AChE) weekly.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 38 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methyl tridecanoate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl tridecanoate inhibits β-amyloid aggregation moderately and inhibits acetylcholinesterase (AChE) weekly.
  • Description
    Methyl tridecanoate inhibits β-amyloid aggregation moderately and inhibits acetylcholinesterase (AChE) weekly.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    methyl tridecanoate
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Beta Amyloid
  • Recptor
    Beta Amyloid
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1731-88-0
  • Formula Weight
    228.376
  • Molecular Formula
    C14H28O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCCCCCCCCC(=O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • β-Amyloid 33-40

    β-Amyloid (33-40) is a peptide consisting of amino acid of 33 to 40 of beta amyloid protein.

  • Amyloid β-Peptide (1...

    Amyloid β-Peptide (1-42) human is a 42-amino acid peptide which plays a key role in the pathogenesis of Alzheimer disease.

  • Lecanemab

    Lecanemab (BAN-2401) is an IgG1 monoclonal antibody targeting soluble aggregated β-amyloid (Abeta) with activity against oligomers, protofibrils, and insoluble protofibrils, and may be useful in the study of Alzheimer's disease (AD)-induced mild cognitive impairment and mild AD dementia.